Chris Hulls - Dec 2, 2024 Form 4 Insider Report for Life360, Inc. (LIF)

Signature
/s/ Jay Sood, Attorney-in-Fact
Stock symbol
LIF
Transactions as of
Dec 2, 2024
Transactions value $
-$250,248
Form type
4
Date filed
12/4/2024, 07:56 PM
Previous filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIF Common Stock Tax liability -$250K -5.08K -0.53% $49.31 948K Dec 2, 2024 Direct F1, F2, F3, F4
holding LIF Common Stock 1.85K Dec 2, 2024 Held by ICCA Labs, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
F2 Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
F3 Includes 55,684 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F4 Due to an administrative error, the previous Form 4 filed on November 15, 2024 inadvertently reported, in Footnote 2 therein, the number of RSUs held by the Reporting Person as 32,010. The correct number of RSUs held by the Reporting Person as of November 15, 2024 was 65,690.
F5 The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.